The First Affiliated Hospital of Nanchang University Branch Xianghu

Nanchang, Jiangxi 332000

2 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Marginal Zone Lymphoma, Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer, Refractory Chronic Lymphocytic Leukemia, Refractory Diffuse Large B-cell Lymphoma, Refractory Follicular Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, Relapse Diffuse Large B Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia

Studies at this site

• A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma — Recruiting now
• A Study of BG-C477 in Participants With Advanced Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies — Stopped early
• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer — Running, not enrolling